• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLBELLA WLIDOCAINE 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLBELLA WLIDOCAINE 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94728II
Device Problems Backflow (1064); Detachment Of Device Component (1104)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 04/08/2018
Event Type  malfunction  
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling: method of use ¿ posology ¿ juvéderm® volbella¿ with lidocaine is to be used as supplied.Modification or use of the product outside the directions for use may adversely impact the sterility, homogeneity and performance of the product and it can therefore no longer be assured.
 
Event Description
Healthcare professional reported injecting a patient with juvéderm volbella with lidocaine in the tear trough (tt2) using the packaged needle.While aspirating at the injection site, the plunger came detached from the syringe and the vacuum release in the syringe led to blood coming into the syringe.Injection was aborted.There was only blood in the syringe due to the vacuum release and there was no bleeding after the removal of the needle from the site of injection.There were no injuries or adverse reactions.
 
Event Description
Healthcare professional reported injecting a patient with juvéderm volbella with lidocaine in the tear trough (tt2) using the packaged needle.While aspirating at the injection site, the plunger came detached from the syringe and the vacuum release in the syringe led to blood coming into the syringe.Injection was aborted.There was only blood in the syringe due to the vacuum release and there was no bleeding after the removal of the needle from the site of injection.There were no injuries or adverse reactions.
 
Manufacturer Narrative
Lab analysis of the device found 1 empty syringe of 1.0ml received in an opened tray with cap and without needle.The plunger rod is disconnected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLBELLA WLIDOCAINE 2 X 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
MDR Report Key7565577
MDR Text Key110033530
Report Number3005113652-2018-00634
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2019
Device Catalogue Number94728II
Device Lot NumberV15LA70473
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/12/2018
Initial Date Manufacturer Received 05/08/2018
Initial Date FDA Received06/04/2018
Supplement Dates Manufacturer Received07/27/2018
Supplement Dates FDA Received08/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-